Clinical Trials Logo

Serpiginous Choroiditis clinical trials

View clinical trials related to Serpiginous Choroiditis.

Filter by:
  • None
  • Page 1

NCT ID: NCT00407121 Withdrawn - Clinical trials for Vogt Koyanagi Harada Disease

Intravitreal Bevacizumab for Inflammatory Neovascular Membranes

Start date: December 2006
Phase: Phase 3
Study type: Interventional

Intravitreal injection of Bevacizumab in patients with Neovascular Membranes secondary to intraocular inflammation. We injected a single injection of Bevacizumab (2.5 mg/0.1 ml) and evaluate visual acuity , Fluorescein angiogram and retinal thickness by Optical Coherence Tomography (OCT) in 4 patients with Vogt Koyanagi Harada disease, 1 patient with Serpiginous Choroidopathy and 1 patient with Multifocal Choroiditis.